
View larger version (121K):
[in a new window]
|
Fig. 7. Targets of Fgf signaling investigated by SU5402 treatment, with DMSO
control. (A,F) Alcian green staining reveals a loss of oral
teeth (arrowhead and inset in A) following SU5402 treatment. Arrowhead
indicates dentary bone in F. (B,C,G,H) Mesenchymal
(arrow), but not epithelial (arrowhead), expression of Astyanax pax9
is absent after SU5402 treatment. Mesenchymal expression of lhx6
(D,I, arrows), epithelial expression of fgf8
(E,J, arrowheads) and dlx2b (L,Q,
arrowheads), and both mesenchymal (arrow) and epithelial (arrowhead)
expression of dlx2a (K,P) in the oral region are absent
after SU5402 treatment in Astyanax.
(M,N,R,S) Oral epithelial expression of
shh and pitx2 remains after SU5402 treatment in
Astyanax. (O,T) Mandibular arch mesenchymal expression
of dlx2a (arrow) in the zebrafish is absent after SU5402 treatment.
(B,D-E,G,I-K,M-P,R-T) Whole-mount ventral views; (A,F,L,Q) lateral views;
(C,H) transverse sections. Abbreviations as in
Fig. 1. a, adhesive gland; f,
forebrain; pq, palatoquadrate; pt, pharyngeal tooth. Scale bars: 100
µm.
|